Medicinal Cannabis in New Zealand
Cannasouth is a biopharmaceutical company dedicated to medicinal cannabis research and product development for prescribers and patients in New Zealand.
Our cannabinoid extracts come from high quality, medical-grade cannabis cultivars. Medicines and supplements will be formulated and manufactured as naturally as possible.
Our products will be produced under GMP & ISO using environmentally friendly methods without the use of harmful chemicals, ensuring patients are treated with pure cannabinoid therapeutic compounds of the highest quality.
Shareholder Roadshow
Cannasouth has successfully completed its inaugural Shareholder Roadshow, with CEO Mark Lucas and team presenting in Christchurch, Wellington, Auckland and Hamilton between 15th and 17th October 2019.
The final presentation in Hamilton on Thursday 17th October was recorded and has been made available to CBD shareholders on Cannasouth’s YouTube page and on the Media Centre page.
Learn
Doctors
Cannasouth provides information, educational material and media for specialists, doctors, and clinicians enabling informed patient treatment choices.
Patients
Supporting patient access to high quality educational material regarding cannabinoid therapeutics is central to meaningful health outcomes.
Investors
Our investors are critical to the success of the company. We acknowledge the special trust they place in us with our commitment to the expansion of Cannasouth.
